Oranex 500 mg Capsule contains tranexamic acid, an anti-fibrinolytic medicine that helps reduce bleeding by stabilising blood clots. It is used in various bleeding conditions as prescribed by a doctor.
There are 35 brands of Tranexamic Acid listed in Bangladesh. 3 of them have a lower unit price than Oranex. The lowest listed price is Enclot 250 mg Capsule at ৳ 8.06 per unit.
What is Oranex 500 mg Capsule?
Oranex 500 mg Capsule is a brand of tranexamic acid, which belongs to a group of medicines called anti-fibrinolytic drugs. It works by preventing the breakdown of blood clots, thereby helping to control bleeding. It is used in medical and surgical situations where excessive bleeding occurs due to increased clot breakdown. The capsule is taken orally, and the dose is determined by the doctor based on the condition. It should be used only under medical supervision. Common side effects may include nausea, diarrhoea, or skin reactions. It is not suitable for people with certain clotting disorders or severe kidney problems.
Uses of Oranex
Oranex 500 mg Capsule is used to prevent and treat bleeding in various medical conditions such as bleeding from the lungs or digestive tract, bleeding disorders related to leukaemia, cirrhosis, or haemophilia, and in surgical procedures to reduce bleeding. It may also be used in accidents during thrombolytic therapy or transfusion. Your doctor will decide if this medicine is appropriate for your specific condition.
How to use Oranex
Take Oranex 500 mg Capsule exactly as prescribed by your doctor. Swallow the capsule whole with water, with or without food. The dose and duration depend on your condition and will be determined by your doctor. Do not change the dose or stop taking it without consulting your doctor. If you miss a dose, take it as soon as you remember, but do not double the dose. Follow your doctor's instructions carefully.
Side effects of Oranex
Oranex 500 mg Capsule is generally well tolerated, but some people may experience side effects. These include fatigue, conjunctival irritation, nasal blockage, itching, skin reddening, rash, nausea, diarrhoea, or heartburn. Rarely, a drop in blood pressure on standing may occur. If you experience any allergic reaction such as itching, rash, or swelling, stop the medicine and contact your doctor immediately. Seek medical help if side effects are severe or persistent.
Safety and precautions
Before taking Oranex 500 mg Capsule, inform your doctor if you have a history of blood clots, kidney problems, or any allergies. It is contraindicated in people with thromboembolic disease, arterial or venous thrombosis, and severe kidney failure. It should not be used during pregnancy unless clearly needed, as its effects on the fetus are unknown. It passes into breast milk in small amounts, but an effect on the infant is unlikely. Always consult your doctor before using this medicine if you are pregnant, breastfeeding, or have any underlying health conditions.
Frequently asked questions
What is Oranex 500 mg Capsule used for and what kind of medicine is it?
Oranex 500 mg Capsule contains tranexamic acid, an anti-fibrinolytic medicine. It is used to prevent and treat bleeding in various medical and surgical conditions by helping to stabilise blood clots. Your doctor will determine if it is suitable for you.
What side effects should I watch for and when should I call my doctor?
Common side effects include nausea, diarrhoea, heartburn, fatigue, itching, or rash. If you experience signs of an allergic reaction such as swelling, difficulty breathing, or severe rash, stop the medicine and seek medical help immediately. Also contact your doctor if side effects persist or worsen.
How should I store Oranex 500 mg Capsule?
Store Oranex 500 mg Capsule in a dry place at a temperature between 15°C and 30°C, away from light. Keep it out of reach of children. Do not use it after the expiry date printed on the pack.
In medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.
In surgery: Prophylaxis and antihemorrhagic ... Read moreIn medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.
In surgery: Prophylaxis and antihemorrhagic therapy during operations of any type and nature and particularly in pulmonary, cardiovascular and abdominal surgery and post-operative and traumatic shock.
In urology: Prophylaxis and antihemorrhagic therapy of prostatic, vesical and renal surgery. Hematurias.
In obstetrics: Prophylaxis and therapy of post-partum and puerperium hemorrhages, hemorrhagic metrophathies, functional menometrorrhagias, idiopathic or IUD(lntra uterine Device) induced menorrhagias, primitive hyperfibrinolysis (abruptio placentae, premature placenta detachment) and in cervical conization.
In otorhinolaryngology: Prophylaxis and antihemorrhagic therapy during a tonsillectomy, specialist surgery generally, epistaxis.
In stomatology: Prophylaxis and antihemorrhagic therapy during maxillofacial operations, tooth extractions.
In oncology (as supportive therapy): To promote the formation of a fibrin capsule to wall off and thereby inhibit the growth of ovarian tumors. To cause regression of ascites secondary to carcinoma. To reduce bleeding during surgical interventions.
Pharmacology
This is a preparation of tranexamic acid (trans-4 aminomethyl-cyclohexanecarboxylic acid). Tranexamic acid is a substance endowed with a strong antifibrinolytic action and both in vivo and in vitro it has proved to be 10 times more active than conventional hemostatics, depending on the test. The antihemorrhagic action of tranexamic acid is essentially due to an inhibition of the plasminogen activation of both exogenous activators like streptokinase and endogenous ones like urokinase and the plasminogen tissue activator. This fact is particularly important for the clinical use of Tranexamic Acid, because it ensures an antihemorrhagic activity with an antifibrinolytic mechanism under a variety of conditions.
The acute toxicity of Tranexamic Acid is extremely low and chronic toxicity almost non-existent. Tranexamic Acid is well absorbed by oral route and the effect is already seen 15-30 minutes after administration. It is excreted mainly by renal route but more slowly than conventional hemostatics. These features make the Tranexamic Acid effect more lasting than those conventional hemostatics. Considerably lower single doses of Tranexamic Acid can thus be administered at greater intervals without the drug plasma levels dropping to inefficient levels of antifibrinolytic activity between one dose and the other.
Tranexamic Acid at therapeutic doses does not interfere with clotting processes and even a prolonged administration has not been seen to be accompanied by any tendency to thrombophilia.
Dosage & Administration
Adults-
The usual dose: 500-1000 mg 3 times daily.
For prophylaxis: The mean recommended daily doses are 0.5-1 gm orally, 500 mg by the parenteral (intravenous or intramuscular) route.
For therapy of hemorrhagic manifestations: the oral dose increases to 1-3 gm given in divided doses: in cases of particular seriousness and urgency, begin by injecting an ampoule (500 mg) slowly by intravenous route and administer the necessary subsequent oral doses.
Children-
For prophylaxis: For every kg of body weight from 5-10 mg are orally administered daily in divided doses.
For therapeutic purposes: The oral doses are doubled (from 10 to 20 mg/kg), while the intravenous and intramuscular treatment is begun with 10 mg/kg (=0.5 ml every 5 kg) by the slow intravenous route, continuing the oral administration up to the required dose. Where it is more convenient (e.g. in small babies) the ampoules, diluted in a little sweetened water, maybe orally administered instead of the Capsules.
Elderly patients: No reduction in dosage is necessary unless there is evidence of renal failure.
Interaction
Tranexamic Acid is a synthetic Amino Acid that is incompatible with solutions containing penicillins (eg: Benzyl penicillin). Thrombolytic drugs like Streptokinase & Urokinase antagonise the antifibrinolytic action of Tranexamic Acid. The potential for thrombus formation may be increased by concomitant administration of estrogen containing drugs, like oral contraceptives. Direct admixture of Tranexamic Acid with whole blood should be avoided during Transfusion.
Contraindications
Known individual hypersensitivity to the product. Thromboembolic disease, arterial and venous thrombosis, endocavitary hemorrhages, serious kidney failure.
Side Effects
Tranexamic Acid is generally well tolerated; there may be infrequent cases of sense of fatigue, conjunctival irritation, nasal blockage, itching, skin reddening, exanthems.
After oral administration there may be sign of nausea, diarrhea, gastric pyrosis.
There are rare cases of postural hypotension.
In the case of hypersensitivity to tranexamic acid, avoid or suspend treatment and start a suitable therapy.
Pregnancy & Lactation
Since the transplacental passage of the drug and its possible effects on the fetus are unknown, Tranexamic Acid should not be administered during known and presumed pregnancy. Tranexamic Acid passes into breast milk to a concentration of approximately one hundredth of the concentration in the maternal blood. An antifibrinolytic effect in the infant is unlikely.
Precautions & Warnings
Tranexamic Acid should be used in cases where there is hyperfibrinolysis. The prophylactic treatment must begin 24 hours before the operation and continue until 3-4 days after it.
The therapy of hemorrhages must be prolonged for at least 24 hours after manifestations have disappeared.
In hematuria, especially when this is not accompanied by any other hemorrhagic manifestations, reduce the doses to prevent formation of clots in the urinary tract.
Tranexamic Acid must not be used in serious renal insufficiency or anuric syndromes and must only be used with caution in less serious renal dysfunctions.
The administration of product requires particular care in cardiopathic and hepatopathic subjects.
Storage Conditions
Store in a dry place at 15-30°C, away from light and keep out of children's reach.
Alternative brands of Tranexamic Acid
Other brands with the same generic name, cheapest first.